Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B

Cancer Research

Volumn 56, Issue 4, 1996, Pages 722-727

  Herman, James G ^a   Jen, Jin ^a   Merlo, Adrian ^a,b   Baylin, Stephen B ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Neurologische Universitatsklinik Basel   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CYCLIN DEPENDENT KINASE; PROTEIN KINASE INHIBITOR; PROTEIN P15; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DRUG RESISTANCE; GENE ACTIVATION; GENE LOSS; GLIOMA; HUMAN; HUMAN CELL; LEUKEMIA; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

ADULT; BREAST NEOPLASMS; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL LINE; CHILD; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 9; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DINUCLEOSIDE PHOSPHATES; DNA; DNA, NEOPLASM; FEMALE; GENES, TUMOR SUPPRESSOR; GLIOMA; HOMOZYGOTE; HUMANS; LEUKEMIA; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; LUNG NEOPLASMS; LYMPHOCYTES; MALE; METHYLATION; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; REFERENCE VALUES; RESTRICTION MAPPING; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0030046322     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E , Day, R. S., Johnson, B. E., and Skolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types Science (Washington DC), 264: 436-440, 1994.
2. Serrano, M., Hannon, G. J., and Beach, D A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366: 704-707, 1993.
3. Nobori, T., Miura, K., Wu, D J , Lois, A., Takabayashi, K , and Carson, D. A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (Lond.), 368: 753-756, 1994.
4. Walker, D. G , Duan, W , Popovic, E. A., Kaye, A. H., Tomlinson, F. H., and Lavin, M. Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytomas. Cancer Res , 55: 20-23, 1995.
5. INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias. Blood, 84: 4038-4044, 1994
6. Cheng, J. Q , Jhanwar, S C , Klein, W M., Bell, D. W., Lee, W. C., Altomare, D A , Nobori, T., Olopade, O. I , Buckler, A. J., and Testa, J. R. p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Res., 54: 5547-5551, 1994.
7. Xu, L , Sgroi, D., Sterner, C. J., Beauchamp, R. L., Pinney, D. M., Keel, S., Ueki, K., Rutter, J. L , Buckler, A. J., Louis, D. N., Louis, D. D., Gusella, J. F., and Ramesh, V. Mutational analysis of CDKN2 (MTS1/p16ink4) in human breast carcinomas. Cancer Res., 54. 5262-5264, 1994.
8. Hannon, G. J., and Beach, D p15INK4B is a potential effector of TGF-β-induced cell cycle. Nature (Lond.), 371: 257-261, 1994.
9. Jen, J., Harper, W., Bigner, S. H., Bigner, D. D., Papadopoulos, N., Markowitz, S., Willson, J. K. V., Kinzler, K. W., and Vogelstein, B. Deletion of p16 and p15 genes in brain tumors Cancer Res., 54 6353-6358, 1994.
10. Hussussian, C. J , Struewing, J. P , Goldstein, A. M., Higgins, P. A., Ally, D. S., Sheahan, M D , Clark, W. H., Jr , Tucker, M A., and Dracopoli, N. C. Germline p16 mutations in familial melanoma Nat. Genet , 8: 15-21, 1994
11. Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J., and Kern, S. E. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat. Genet , 8. 27-32, 1994
12. Okamoto, A , Demetrick, D. J., Spillare, E. A., Hagiwara, K., Hussain, S. P., Bennett, W P , Forrester, K., Gerwin, B., Serrano, M., Beach, D. H , and Harris, C C. Mutations and altered expression of p16INK4 in human cancer Proc. Natl. Acad. Sci. USA, 91: 11045-11049, 1994.
13. Spruck, C. H., Gonzalez-Zulueta, M., Shibata, A., Simoneau, A. R., Lin, M. F., Gonzales, F., Tsai, Y. C., and Jones, P. A. p16 gene in uncultured tumours. Nature (Lond.), 370: 183-184, 1994.
14. Cairns, P., Mao, L., Merlo, A., Lee, D. J , Schwab, D., Eby, Y , Tokino, K., van der Riet, P , Blaugrund, J E., and Sidransky, D. Rates of p16 (MTS1) mutations in primary tumors with 9p loss Science (Washington DC), 265: 415-417, 1994.
15. Mori, T., Miura, K., Aoki, T., Nishihira, T., Mori, S., and Nakamura, Y. Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res., 54. 3396-3397, 1994.
16. Washimi, O , Nagatake, M., Osada, H., Ueda, R., Koshikawa, T., Seki, T., Tokahashi, T., and Takahashi, T In vivo occurrence of p16 (MTS1) and p15 (MTS2) alterations preferentially in non-small cell lung cancers. Cancer Res., 55: 514-517, 1995
17. INK4B/MTS2 in human leukemias and lymphomas Cancer Res., 55: 1436-1440, 1995.
18. INK4b/MTS2 in pediatric acute lymphoblastic leukemia. Blood. 85: 2321-2330, 1995
19. Stone, S., Dayananth, P., Jiang, P , Weaver-Geldhous, J M., Tavtigian, S. V., Cannon-Albright, L., and Kamb, A Genomic structure, expression and mutational analysis of the p15 (MTS2) gene. Oncogene, 11: 987-991, 1995.
20. Hatta, Y., Hirama, T., Miller, C. W., Yamada, Y., Tomonaga, M., and Koeffler, H. P. Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia Blood, 85. 2699-2704, 1995.
21. Stone, S., Jiang, P., Dayananth, P., Tavtigian, S V., Katcher, H , Parry, D., Peters, G., and Kamb, A Complex structure and regulation of the p16 (MTS1) locus. Cancer Res., 55. 2988-2994, 1995.
22. Reynisdóttir, I., Polyak, K., Iavarone, A., and Massagúe, J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes & Dev., 9: 1831-1845, 1995.
23. Merlo, A., Herman, J. G., Mao, L , Lee, D. J , Gabrielson, E., Burger, P. C., Baylin, S. B., and Sidransky, D. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med., 1. 686-692, 1995.
24. Herman, J. G , Merlo, A , Mao, L., Lapidus, R. G., Issa, J-P. J , Davidson, N E., Sidransky, D., and Baylin, S B Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res , 55: 4525-4530, 1995.
25. Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B , Liu, S., Samid, D., Duan, D S., Gnarra, J. R., Linehan, W. M., and Baylin, S. B. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA, 91: 9700-9704, 1994
26. Gonzalez-Zulueta, M., Bender, C. M., Yang, A S , Nguyen T., Beart, R. W , Van Tornour, J. M., and Jones, P. A Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res., 55: 4531-4535, 1995.
27. INK4 protein inductin by 5-aza 2′deoxycytidine Oncogene, 11. 1211-1216, 1995.
28. de Bustros, A., Nelkin, B. D., Silverman, A., Ehrlich, G., Poiesz, B , and Baylin S. B. The short arm of chromosome 11 is a "hot spot" for hypermethylation in human neoplasia. Proc. Natl. Acad. Sci. USA, 85: 5693-5697, 1988.
29. Bird, A P CpG-rich islands and the function of DNA methylation. Nature (Lond.), 321: 209-213, 1986.
30. Nakamaki, T., Kawamata, N., Schwaller, J., Tobler, A., Fey, M., Pakkala, S., Lee, Y. Y., Kim, B. K., Rukuchi, K., Tsuruoka, N., Kahan, J , Miller, C W., and Koeffler, H. P. Structural integrity of the cyclin-dependent kinase inhibitor genes p15, p16, and p18 in myeloid leukaemias. Br. J. Haematol., 91: 139-149, 1995.
31. Fizotti, M., Cimino, G., Pisegna, S., Alimena, G., Quartarone, C. Mandelli, F., Pelicci, P G., and Lo Coco, F Detection of homozygous deletions of the cyclin-dependent kinase 4 inhibitor (p16) gene in acute lymphoblastic leukemia and association with adverse prognostic features. Blood, 85: 2685-2690, 1995.
32. Ogawa, S., Hirano, N., Sato, N., Takahashi, T., Hangaishi, A., Tanaka, K., Kurokawa, M , Tanaka, T., Mitani, K., Yazaki, Y., and Hirai, H. Homozygous loss of the cyclin-dependent kinase 4-inhibitor (p16) gene in human leukemias Blood, 84: 2431-2435, 1994.
33. Laiho, M. DeCaprio, J. A., Ludlow, J. W., Livingston, D. M., and Massaguè, J. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell, 62: 175-185, 1990.
34. Hooper, W. C. The role of transforming growth factor-β in hematopoiesis. A review. Leuk. Res., 15: 179-184, 1991.
35. Thompson, N. L , Randers, K. C., Smith, J. M., Ellingsworth, L. R., Roberts, A. B., and Sporn, M. B. Expression of transforming growth factor-β1 in specific cells and tissues of adult and neonatal mice. J. Cell Biol., 108: 661-669, 1989.
36. Ellingsworth, L. R., Brennan, J. E., Fok, K., Rosen, D. M., Bentz, H., Peiz, K. A., and Seyedin, S M. Antibodies to the N-terminal portion of cartilage-inducing factor A and transforming growth factor β. J. Biol. Chem., 261: 12362-12367, 1986.
37. Piacibello, W., Severino, A., Stacchini, A., and Aglietta, M. Differential effect of transforming growth factor β1 on the proliferation of human lymphoid and myeloid leukemia cells. Haematologica, 76: 460-466, 1991.
38. Hooper, W. C., Pruckler, J., Jackson, D., and Evatt, B. L. Transforming growth factor-β induces hemoglobin synthesis in a human erythroleukemia cell line. Biochem Biophys. Res. Commun., 165: 145-150, 1989.
39. Shull, M. M., Ormby, I., Kier, A. B., Pawlowshi, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., Nikki, A., and Doetschman, T. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature (Lond.), 359: 693-699, 1992